Articles

SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders

Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy;Università degli Studi di Milano-Bicocca, Milano, Italy
Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy
Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy
Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy
Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy
Pathology Unit, Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milano, Italy
Pathology Unit, Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milano, Italy
The Institute of Molecular Oncology (IFOM) of the Italian Foundation for Cancer Research (FIRC), Milano, Italy
Department of Biology, Nikolaus Fiebiger Center for Molecular Medicine, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany
Department of Biology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany
Pathology Unit, Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milano, Italy;Clinical Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milano, Italy
Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy;Clinical Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milano, Italy;Vita-Salute San Raffaele University, Milano, Italy
Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy;Clinical Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milano, Italy;Vita-Salute San Raffaele University, Milano, Italy
Vol. 99 No. 8 (2014): August, 2014 https://doi.org/10.3324/haematol.2013.100230